These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 22289163)

  • 21. Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression.
    Paradis JS; Ly S; Blondel-Tepaz É; Galan JA; Beautrait A; Scott MG; Enslen H; Marullo S; Roux PP; Bouvier M
    Proc Natl Acad Sci U S A; 2015 Sep; 112(37):E5160-8. PubMed ID: 26324936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucose-dependent insulinotropic polypeptide activates the Raf-Mek1/2-ERK1/2 module via a cyclic AMP/cAMP-dependent protein kinase/Rap1-mediated pathway.
    Ehses JA; Pelech SL; Pederson RA; McIntosh CH
    J Biol Chem; 2002 Oct; 277(40):37088-97. PubMed ID: 12138104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropeptide Y receptor mediates activation of ERK1/2 via transactivation of the IGF receptor.
    Lecat S; Belemnaba L; Galzi JL; Bucher B
    Cell Signal; 2015 Jul; 27(7):1297-304. PubMed ID: 25817573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracellular signal-regulated kinase 1/2 activation by myometrial oxytocin receptor involves Galpha(q)Gbetagamma and epidermal growth factor receptor tyrosine kinase activation.
    Zhong M; Yang M; Sanborn BM
    Endocrinology; 2003 Jul; 144(7):2947-56. PubMed ID: 12810550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms that underlie the internalization and extracellular signal regulated kinase 1/2 activation by PKR2 receptor.
    Yin W; Liu H; Peng Z; Chen D; Li J; Li JD
    Cell Signal; 2014 May; 26(5):1118-24. PubMed ID: 24509228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium-sensing receptor-mediated ERK1/2 activation requires Galphai2 coupling and dynamin-independent receptor internalization.
    Holstein DM; Berg KA; Leeb-Lundberg LM; Olson MS; Saunders C
    J Biol Chem; 2004 Mar; 279(11):10060-9. PubMed ID: 14701866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. G protein-coupled estrogen receptor 1 (GPER1)/GPR30 increases ERK1/2 activity through PDZ motif-dependent and -independent mechanisms.
    Gonzalez de Valdivia E; Broselid S; Kahn R; Olde B; Leeb-Lundberg LMF
    J Biol Chem; 2017 Jun; 292(24):9932-9943. PubMed ID: 28450397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transactivation of epidermal growth factor receptor through platelet-activating factor/receptor in ovarian cancer cells.
    Yu Y; Zhang M; Zhang X; Cai Q; Zhu Z; Jiang W; Xu C
    J Exp Clin Cancer Res; 2014 Sep; 33(1):85. PubMed ID: 25261977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. beta-Arrestin 2 expression determines the transcriptional response to lysophosphatidic acid stimulation in murine embryo fibroblasts.
    Gesty-Palmer D; El Shewy H; Kohout TA; Luttrell LM
    J Biol Chem; 2005 Sep; 280(37):32157-67. PubMed ID: 16027114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of beta-arrestins on the internalization, desensitization and ERK1/2 activation downstream of protease activated receptor-2.
    Kumar P; Lau CS; Mathur M; Wang P; DeFea KA
    Am J Physiol Cell Physiol; 2007 Jul; 293(1):C346-57. PubMed ID: 17442737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. beta-Arrestin 1 is required for PAC1 receptor-mediated potentiation of long-lasting ERK1/2 activation by glucose in pancreatic beta-cells.
    Broca C; Quoyer J; Costes S; Linck N; Varrault A; Deffayet PM; Bockaert J; Dalle S; Bertrand G
    J Biol Chem; 2009 Feb; 284(7):4332-42. PubMed ID: 19074139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-transactivational, dual pathways for LPA-induced Erk1/2 activation in primary cultures of brown pre-adipocytes.
    Holmström TE; Mattsson CL; Wang Y; Iakovleva I; Petrovic N; Nedergaard J
    Exp Cell Res; 2010 Oct; 316(16):2664-75. PubMed ID: 20576526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Independent beta-arrestin2 and Gq/protein kinase Czeta pathways for ERK stimulated by angiotensin type 1A receptors in vascular smooth muscle cells converge on transactivation of the epidermal growth factor receptor.
    Kim J; Ahn S; Rajagopal K; Lefkowitz RJ
    J Biol Chem; 2009 May; 284(18):11953-62. PubMed ID: 19254952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of GPR18 by cannabinoid compounds: a tale of biased agonism.
    Console-Bram L; Brailoiu E; Brailoiu GC; Sharir H; Abood ME
    Br J Pharmacol; 2014 Aug; 171(16):3908-17. PubMed ID: 24762058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progesterone receptors upregulate Wnt-1 to induce epidermal growth factor receptor transactivation and c-Src-dependent sustained activation of Erk1/2 mitogen-activated protein kinase in breast cancer cells.
    Faivre EJ; Lange CA
    Mol Cell Biol; 2007 Jan; 27(2):466-80. PubMed ID: 17074804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Constitutive ERK1/2 activation by a chimeric neurokinin 1 receptor-beta-arrestin1 fusion protein. Probing the composition and function of the G protein-coupled receptor "signalsome".
    Jafri F; El-Shewy HM; Lee MH; Kelly M; Luttrell DK; Luttrell LM
    J Biol Chem; 2006 Jul; 281(28):19346-57. PubMed ID: 16670094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholecystokinin stimulates extracellular signal-regulated kinase through activation of the epidermal growth factor receptor, Yes, and protein kinase C. Signal amplification at the level of Raf by activation of protein kinase Cepsilon.
    Piiper A; Elez R; You SJ; Kronenberger B; Loitsch S; Roche S; Zeuzem S
    J Biol Chem; 2003 Feb; 278(9):7065-72. PubMed ID: 12496267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of EGF receptor transactivation in phosphoinositide 3-kinase-dependent activation of MAP kinase by GPCRs.
    Shah BH; Neithardt A; Chu DB; Shah FB; Catt KJ
    J Cell Physiol; 2006 Jan; 206(1):47-57. PubMed ID: 15920762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted Elimination of G Proteins and Arrestins Defines Their Specific Contributions to Both Intensity and Duration of G Protein-coupled Receptor Signaling.
    Alvarez-Curto E; Inoue A; Jenkins L; Raihan SZ; Prihandoko R; Tobin AB; Milligan G
    J Biol Chem; 2016 Dec; 291(53):27147-27159. PubMed ID: 27852822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The signaling signature of the neurotensin type 1 receptor with endogenous ligands.
    Besserer-Offroy É; Brouillette RL; Lavenus S; Froehlich U; Brumwell A; Murza A; Longpré JM; Marsault É; Grandbois M; Sarret P; Leduc R
    Eur J Pharmacol; 2017 Jun; 805():1-13. PubMed ID: 28341345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.